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Introduction
Endoscopic mucosal resection (EMR) and endoscopic submuco-
sal dissection (ESD) are established techniques for the treat-
ment of precancerous lesions and early stage cancer in the wes-
tern world [1, 2]. The ESD technique was originally developed
for the resection of gastric neoplasms, but is increasingly used
in the colon and the esophagus. Compared to EMR, ESD has cer-
tain advantages, including a higher rate of en bloc resection
with a precise histopathological examination. In addition, re-
section of larger (> 2 cm) lesions is possible with simultaneously
lower recurrence rates [3–5]. On the other hand, ESD is an ad-
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ABSTRACT
Introduction Endoscopic submucosal dissection (ESD) is
increasingly being used in the western world. Submucosal
injectates are an essential tool for the ESD procedure. In
this study, we evaluated a novel copolymer injectate (Lift-
Up, Ovesco, Tübingen Germany) in an established ESD
model (EASIE-R) in comparison to existing submucosal in-
jectables.
Materials and methods We conducted a prospective,
randomized ex vivo study performing ESD with three injec-
tates: LiftUp, hydroxyethyl starch (HAES 6%) and normal
saline solution (NaCl 0.9%). A total of 60 artificial lesions,
each 3×3 cm in size, were resected in an ex vivo porcine
model, utilizing one of the three studied injectates (n=20
ESDs per injectate). Study parameters were: en bloc resec-
tion rate, perforation rate, lifting property, time of injec-
tion, injectate volume, general ESD procedure time, and
overall procedure time.
Results All 60 lesions were successfully resected using the
standard ESD technique. LiftUp had no procedure related
perforations, one perforation occurred in the HAES group,
and two perforations in the NaCl group (P >0.05). Further-
more, adequate lifting was achieved in 16/20 (80%) using
LiftUp, 6/20 (30%) in the HAES group and 6/20 (30%) in
the NaCl group (P<0.0002). En bloc resection was achieved
in 19 (95%) with LiftUp, in 20 (100%) with HAES, and in 16
(80%) with NaCl. General ESD procedure time and overall
procedure time were not different among the three groups.
Conclusion LiftUp appears to be a safe alternative to es-
tablished fluids for ESD. It had a significantly improved lift-
ing effect and required significantly less injected volume
compared to well-established lifting solutions.
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vanced technique with a long learning curve, even for experi-
enced endoscopists, has a longer procedure time than EMR
and a higher incidence of adverse events. One of the major
complications is perforations, with an incidence up to 4–10%
[2]. For that reason, perforation prevention is essential, and
the most effective way to do this is to use an adequate and ef-
fective submucosal fluid cushion [6]. For this reason, the ESGE
guidelines specify an ideal submucosal injection fluid which
provides a sustainable lift, facile en bloc resection, low cost,
widespread availability and few adverse events [7].
To date, the most studied injection fluid is NaCl 0.9%, begin-
ning in the early 1950s [8], and with the advantages of wide-
spread availability and low cost [9, 10]. The limitation of NaCl
0.9% is that it does not provide a long lasting cushion effect
and repeated injections are necessary even after a short period
of time, which prolongs the procedure time [11, 12].
Other solutions studied include gelatin, hydroxypropylme-
thylcellulose (HPMC), hydroxyethyl starch (HAES) (Hetastarch,
Hespan), hyaluronic acid, glucose, dextrose, fructose, glycer-
ine, Na-alginate, Eleview (Aries Pharmaceuticals, San Diego, Ca-
lifornia, United States) and mixtures of all those components
[9, 13]. Up to now, no clear recommendation exists to support
the use of one fluid over another; however, comments have
been made in position and guideline papers (ESGE) promoting
the use of more viscous substances over normal saline in EMR
[7, 14]. There is an absolute necessity for research in this field.
It is for this reason that a new highly viscous injectate solu-
tion (LiftUp, Ovesco Endoscopy AG, Tübingen, Germany) was
developed. LiftUp is composed of distilled water, and a co-poly-
mer derived from ethylene oxide, propylene oxide and sodium
chloride, and has a thermo-gelling behavior. It is a co-polymer,
which is fluid at low temperatures, and forming micelles above
a critical temperature. The micelles connect above the critical
micelle temperature and form a grid, which increases the visc-
osity of the fluid. Maximum viscosity is reached at body tem-
perature (37 °C). This is a reversible effect, which allows for
washing out LiftUp by cooling the resection site with cold wa-
ter. It builds a gelatinous cushion, which remains stable and
therefore enables subsequent resection without reinjection.
The aim of this study is to evaluate different parameters of
the ESD procedure with the thermo-sensitive injectate LiftUp
in comparison to NaCl 0.9% and HAES 6% (control group) in an
established ex vivo ESD model.
Materials and methods
This study was exempt from IRB review since no animal or hu-
man subjects were included. It was designed as a prospective,
randomized ex vivo study. The experiments were carried out at
the Federal Research Institute for Animal Health in Mariensee,
Germany. Stomachs from pigs (German Landrace, live weight
60 kg) were cleaned and frozen after slaughtering. The sto-
machs were thawed before the procedure and placed in the EA-
SIE-R simulator (▶Fig. 1). This model has previously been eval-
uated in different endoscopic procedures and is an established
model for interventional endoscopic training and research [15,
16].
All 60 procedures were performed by one endoscopist, who
had previous experience in performing gastric ESD in the ex
vivo simulator (> 60 ESDs before this study) and was blinded to
the injection fluid used.
LiftUp was compared to two standard submucosal injection
fluids: hydroxyethyl starch (HAES 6%, B. Braun, Melsungen,
Germany) and normal saline (NaCl 0.9%, B. Braun, Melsungen,
Germany). In total, 20 ESD procedures were performed for each
injection fluid.
Preparation of LiftUp for submucosal injection
At low temperatures, LiftUp is liquid and forms a gel-like consis-
tency with increasing temperature. Due to its higher viscosity,
an inflation device (Accura Medizintechnik GmbH, Ref. no.
8610230S) was used to deliver the material through the injec-
tion needle (needle length 6mm, needle diameter 0.7mm),
providing a pressure of up to 20 bars. To keep the conditions
comparable, the same injection needle was also used for HAES
and NaCl injections. After submucosal injection of LiftUp, the
material was then left in place in the submucosa for approxi-
mately 1–3 minutes to form the desired gel-like configuration.
A water bath at 37 °C was used to simulate the in vivo environ-
ment and keep the porcine stomach homothermal (▶Fig. 1).
After 5 minutes, endoscopic resection was initiated. Lifting
properties were measured by the blinded researcher using a
subjective score from 1 to 5 points, with 5 points being the
best valuation and representing properties of an ideal lifting in-
jection with an efficient submucosal cushion. Ovesco is cur-
rently in the process of applying for CE marking for LiftUp.
ESD procedure
Before the interventions, standardized lesions, each measuring
3×3 cm, were manually placed in the corpus of the porcine
stomach (▶Fig. 2). The stomach was placed in the EASIE-R
model, which consists of a plastic hull, where the esophagus
and the pig stomach are secured [15]. Six ESD lesions were cre-
ated per ex vivo stomach. The endoscopist was blinded with re-
gard to which injection solution was provided for the resection.
▶ Fig. 1 EASIE-R simulator for ESD procedures. The porcine stom-
ach is thawed before the procedure and placed in the EASIE-R
simulator. A water bath at 37 °C was used to simulate the in vivo
environment and keep the porcine stomach homothermal.
E642 Wedi E et al. Endoscopic submucosal dissection… Endoscopy International Open 2019; 07: E641–E646
Original article
Th
is
 d
oc
um
en
t w
as
 d
ow
nl
oa
de
d 
fo
r p
er
so
na
l u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
ist
rib
ut
io
n 
is 
st
ric
tly
 p
ro
hi
bi
te
d.
For randomization, 60 identical lots (20 for each injection solu-
tion) were drawn from a pot. Before injection, the LiftUp solu-
tion was stored cooled between 2 °C and 8 °C in a refrigerator.
All lesions were resected using the classic ESD technique. The
procedures were performed sequentially, over a study period
of 1 month. ESD was performed using a gastroscope (EG-530D
Fujinon, Fujifilm, Japan), an ESD cap (DH 29CR ST, Hood short
type, Fujifilm, Japan) and a FlushKnife 1.5mm (Fujinon, Fujifilm,
Japan). Injection fluids were mixed with Methylene Blue dye
(Amino AG, Gebenstorf, Switzerland) to optimize visualization
and differentiation of submucosal fibers during the ESD. The
electrosurgical unit used was the ERBE VIAO 200 (ERBE Elektro-
medizin, Tübingen, Germany). For the ESD, the settings on the
ERBE device were EndoCut Q 1/1/1.
Data collection
An independent observer recorded the following parameters:
time required for fluid injection, amount of fluid injected, time
required for circumferential incision, ESD procedure time, over-
all procedure time (submucosal dissection time), en bloc resec-
tion rate, and perforation rate. Data concerning all parameters
mentioned were collected during each ESD. The resected speci-
mens were spread and pinned on cork plates after each ESD
procedure and photo documented (▶Fig. 3). The ESD proce-
dure time was defined as the time from the beginning of the
ESD procedure, after circumferential incision, to complete re-
section of the lesion from the porcine stomach. Each resection
site was evaluated visually from the endoscopic site in addition
to an insufflation test to determine the presence of a perfora-
tion.
Statistical analysis
Data analysis was performed using JMP 11 (SAS Institute Inc.,
2014) and R 3.3.3 (R Core Team, 2017) software. Box and whis-
ker plots were used to graphically represent the spread in the
data by showing the quartiles of the data along with the ex-
treme values. The bottom and top of the box are the 25th (Q1)
and 75th (Q3) percentiles, and the band near the middle of the
box is the median (50th percentile, Q2). The ends of the whis-
kers represent Q1 minus 1.5 × interquartile range (IQR) and Q3
plus 1.5× IQR, respectively.
For continuous variables (injection time, etc.), differences
between injection fluid groups were tested using a Kruskal–
Wallis test (one-way ANOVA on ranks), followed by nonpara-
metric comparisons of each pair using the Wilcoxon method
when the global test was significant. For binary variables (en
bloc resection and adverse events), we used Fisher’s exact test
to compare the differences between injection fluid groups. A
P value less than 0.05 was considered to be statistically signifi-
cant.
Results
Injection time for the submucosal injectates
Due to its more viscous properties, the injection time with Lift-
Up (median 4 minutes, range 2–7.8 minutes) was significantly
longer than HAES (median 3 minutes, range 1–6.9 minutes,
P=0.0177), and NaCl (median 3 minutes, range 1–6 minutes,
P=0.025).
▶ Fig. 2 Standardized lesions to be resected by ESD were manually
placed in the corpus of porcine stomach, each measuring 3×3 cm.
▶ Fig. 3 Steps in the ESD procedure with LiftUp. a Submucosal
cushion after LiftUp injection. b –d Submucosal dissection with a
FlushKnife. The submucosal cushion remains stable with LiftUp
during the entire procedure. The specimen was spread and pinned
on a cork mat after the ESD procedure.
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Lifting properties and required volume of the
submucosal injectates
The lifting persistency of all three injection solutions is present-
ed in ▶Fig. 4. Injection with LiftUp received the best scores
with 16 of 20 receiving 5 points. The median quality score for
HAES=4 vs. median LiftUp 5, P=0.0005. The median quality
score for NaCl = 3 vs. LiftUp 5, P=0.0002.
The overall injection volume needed for adequate lifting
during ESD was significantly lower in the LiftUp group compar-
ed to the HAES (median 33.5mL vs. 231mL, P<0.0001) or nor-
mal saline groups (median 33.5mL vs. 299mL, P<0.0001)
(▶Fig. 5). Within 60 minutes of the injection, only LiftUp per-
mitted a stable cushion.
With regard to the time required for the circumferential cut,
there was no statistically significant difference between the in-
jection groups (LiftUp vs. HAES: median 10.5 minutes vs. 8.0
minutes, P=0.5688/LiftUp vs. NaCl: median 8.0 minutes vs.
7.5 minutes, P=0.2219).
The variability of the ESD procedure time was lower in the
LiftUp group compared to the other two groups. However, de-
spite a trend towards lower ESD procedure time in the LiftUp
group compared to the NaCl group, the differences did not
reach statistical significance (LiftUp vs. HAES: median 19.5 min-
utes vs. 22.0 minutes, P=0.3296/LiftUp vs. NaCl: 19.5 minutes
vs. 25.0 minutes, P=0.0544) (▶Fig. 6).
Similarly, there were no statistically significant differences in
total procedure time between groups.
En bloc resection rate
En bloc resection was achieved in 20 out 20 ESD cases when
HAES was used, compared to 19 out of 20 ESDs in the LiftUp
group and 16 out of 20 ESDs in the NaCl group (P >0.05).
Adverse events
Due to the ex vivo nature of the ESD model, peri- or post-ESD
bleeding was not able to be simulated. No perforation occurred
during ESD in the LiftUp group (n=0/20), whereas one perfora-
tion occurred in the HAES group (1/20) and two in the normal
saline group (2/20) (P>0.05).
Discussion
The purpose of this study was to evaluate the performance
characteristics of three submucosal injection materials for
ESD, including a new thermosensitive co-polymer (LiftUp), in
comparison to established injectates. ESD and EMR are mini-
mally invasive endoscopic procedures increasingly accepted
for treatment of dysplastic and early malignant lesions limited
to the superficial layers of the gastrointestinal wall [13, 17].
The disadvantages of EMR are a relatively higher recurrence
▶ Fig. 4 Lifting persistency under simulation circumstances in the porcine model for HAES 6%, LiftUp, and NaCl 0.9%.
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rate, especially when piecemeal EMR is performed [18]. ESD is
superior to EMR in achieving en bloc resection for large lesions
[19].
The submucosal cushion, produced with the injection of a
solution into the submucosal space, is an essential step in ESD
with regard to ensuring the safety and efficiency of the proce-
dure. An ideal injection substance should create a long lasting
“cushion” effect by expanding the submucosal space, thereby
preventing perforations and limiting the need of recurrent in-
jections.
The ESGE guidelines have recommended more viscous injec-
tion solutions over the use of normal saline for endoscopic mu-
cosal resections [7]. Special technical recommendations con-
cerning injection fluids in ESD do not exist yet and most of the
commonly used submucosal injectates are used off-label for
ESD at this time [20].
To date, there have been a number of trials comparing dif-
ferent submucosal injection fluids for ESD use [21–26]. Fer-
reira et al. have investigated a number of existing injection so-
lutions in a meta-analysis, including 11 randomized controlled
trials (RCTs) with two on ESD. They concluded that sodium hya-
luronate and normal saline injectates were clinically equivalent
[13]. Recently, Spadaccini et al. published an RCT in a porcine
model showing that a new biocompatible polymer SIC-8000
(Eleview) was more effective for ESD and EMR compared to sal-
ine solution [27]. Mehta et al. found that lower injection vol-
umes and fewer repeat injections were required with HAES and
Eleview in comparison to normal saline for the same mucosal
lifting effect [26].
In general, normal saline is reported to be a safe solution
with regard to adverse events and cost-effectiveness. In terms
of mucosa lifting, it is inferior to more viscous solutions [13]. In
an RCT, hydroxyethyl starch has been shown to increase muco-
sal lifting time and reduce the need for additional injections in
comparison to normal saline solution [28].
A newly developed injection material, LiftUp, is currently un-
dergoing investigation for its use in ESD and EMR. In this study,
we conducted a prospective, randomized ex vivo study compar-
ing the new fluid with two well-investigated injectates, normal
saline solution and HAES. The results of this study demonstrate
that LiftUp had significantly better lift quality scores and requir-
ed significantly less volume injected when compared to HAES
and NaCl. LiftUp provided a more long lasting cushion effect,
which enabled a secure submucosal dissection with no perfora-
tions in the LiftUp group. As a result of its higher viscosity, the
injection time for LiftUp was statistically longer than for NaCl
0.9% and HAES 6%, but significantly less volume of LiftUp was
needed. In the LiftUp group, we performed one injection at the
beginning of the procedure and no more repeat injections were
required for the remainder of the ESDs. Furthermore, at body
temperature, the LiftUp material does not diffuse into the sur-
rounding tissue. In this study, we found that procedure times
and complications were not significantly different between
groups.
This current study does have some limitations. First, the co-
polymer was only compared to HAES 6% and NaCl 0.9% and not
to all injectates available for ESD. However, to date, HAES 6%
and NaCl 0.9% are the best studied injectates. A further limita-
tion is that the research was performed in an ex vivo model. The
effects of blood flow, tissue movement, tissue healing, histopa-
thological evaluation, and other physiological factors which
may affect tissue fluid diffusion and durability of a submucosal
cushion could not be investigated.
We conclude that LiftUp has similar safety and efficiency
qualities compared to NaCl and HAES, but requires significantly
less injected volume and has a preferable subjective quality
score to the blinded endoscopist. LiftUp, with its characteristic
of a thermally sensitive transition by body temperature, can ef-
fectively maintain mucosal elevation, and has ideal lifting prop-
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▶ Fig. 6 ESD procedure time (minutes) dependent on the injection
substance.
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erties. Further clinical studies are warranted, to analyze its
characteristics in human ESD procedures.
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